Sacubitril/valsartan in the treatment of systemic right ventricular failure.

Tjitske E ZandstraMarieke NederendMonique R M JongbloedPhilippine KièsHubert W VliegenBerto J BoumaLaurens F TopsMartin J SchalijAnastasia D Egorova

Published in: Heart (British Cardiac Society) (2021)

We describe the first patient cohort with systemic RV failure treated with sacubitril/valsartan. Treatment appears feasible with improvements in NT-pro-BNP and echocardiographic function. Our positive results show the potential of sacubitril/valsartan for this patient population.

Keyphrases

ejection fraction
case report
mycobacterium tuberculosis
mitral valve
replacement therapy